The Patent Finder
US

Ablation Device

US 8,277,445 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Oct 2, 2024 on the fee record · High confidence

Third maintenance fee unpaid; grace period ended.

Filed Mar 8, 2010 as application 12/719,714 · Granted Oct 2, 2012
Base term, 20 years from filing
Today
Lapsed Oct 2, 2024
2005 2026
Clock starts
Apr 28, 2005
No longer in force
Oct 2, 2024
Granted
Oct 2, 2012
Term would have run to
Apr 28, 2025
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,674,260, to Apr 28, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

Its term would have run to Apr 28, 2025: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 28, 2005, when application 11/118,653, the earliest non-provisional in its chain, was filed (this one was filed Mar 8, 2010)Apr 28, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,674,260)resolves to Apr 28, 2025, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidlapsed Oct 2, 2024High confidence
Computed term endThe steps above, in orderOct 2, 2024High confidence

This family

US 7,674,260In force
Nov 2026
Nov 2026
Application PCT/US2006/014898PCT application
no patent term
no patent term
US 8,277,445this patent
Oct 2024
Oct 2024
US 8,523,856Term ended
Apr 2025
Apr 2025
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 15, 2010
Reel 24239, frame 432
Cytyc CorporationGoldman Sachs Credit Partners L.P., as Collateral AgentTwenty-Second Supplement to Patent Security Agreement
Aug 26, 2010
Reel 24892, frame 1
Goldman Sachs Credit Partners, L.P., as Collateral AgentHologic, Inc.; R2 Technology, Inc.; Suros Surgical Systems, Inc.; Biolucent, LLC; Direct Radiography Corp.; Cytyc Surgical Products II Limited Partnership; Cytyc Surgical Products Limited Partnership; Cytyc Corporation; Cytyc Surgical Products III, Inc.; Cytyc Prenatal Products Corp.; Third Wave Technologies, Inc.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentHologic, Inc.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentR2 Technology, Inc.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentSuros Surgical Systems, Inc.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentBiolucent, LLCTermination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentDirect Radiography Corp.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentCytyc Surgical Products II Limited PartnershipTermination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentCytyc Surgical Products Limited PartnershipTermination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentCytyc CorporationTermination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentCytyc Surgical Products III, Inc.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentCytyc Prenatal Products Corp.Termination of Patent Security Agreements and Release of Security Interests
Aug 26, 2010
reel/frame not recorded
Goldman Sachs Credit Partners, L.P., as Collateral AgentThird Wave Technologies, Inc.Termination of Patent Security Agreements and Release of Security Interests
Jul 18, 2012
Reel 28575, frame 537
Sampson, Russel M.; Skalnyi, Eugene V.Cytyc CorporationAssignment of Assignor's Interest
Aug 1, 2012
Reel 28810, frame 745
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank USASecurity Agreement
Jun 4, 2015
Reel 35820, frame 239
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipSecurity Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedSecurity Interest Release Reel/Frame 028810/0745
Aug 7, 2015
Reel 36307, frame 199
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.Bank of America, N.A., as Collateral AgentSecurity Agreement
Nov 9, 2017
Reel 44432, frame 565
Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedGoldman Sachs Bank USACorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement.
Nov 9, 2017
Reel 44727, frame 529
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe IncorporatedCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentHologic, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentBiolucent, LLCCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc CorporationCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentCytyc Surgical Products, Limited PartnershipCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentSuros Surgical Systems, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentThird Wave Technologies, Inc.Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
reel/frame not recorded
Goldman Sachs Bank USA, as Collateral AgentGen-Probe IncorporatedCorrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Apr 28, 2026
Reel 75566, frame 39
Bank of America, N.A., as Collateral AgentHologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited